Search

everythinglearnresearchcommunity

for

Search:↓

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

IL10_ApoEVs improve skin healing and reduce scarring.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Increasing sebum production might help reduce fat and improve metabolism.

Aging can lead to poorer scalp and hair health, including less hair and more scalp diseases, which should be managed to help older people feel better.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.